Pharmacogenetic analyses are not yet widely spread.
Although the interaction of drugs and enzymes is well known, there are only a few detailed lists of the responsibility of enzymes for the metabolism and/or transport of drugs.
For this reason, PharmGenetix prepared information material that allows you to quickly and easily determine whether a drug is of pharmacogenetic relevance. So you know immediately which enzymes you need to pay attention to if you want to prescribe a drug.
This information is particularly valuable for polypharmacy. When two or more drugs are administered, enzyme inhibitors and activators, as well as transporters, can cause phenotype conversion. This means that, for example, in the case of an intermediate metabolizer of CYP2D6, simultaneous administration of a CYP2D6 inhibitor can convert the patient’s phenotype to that of a poor metabolizer.